Top Industry Leaders in the Diabetic Lancing Device Market
Latest Diabetic lancing device Companies Updates
Owen Mumford acquires Jiangsu Hengrui Medicine's diabetes care business: This December 2023 deal strengthens Owen Mumford's presence in the Chinese market, a key driver of market growth.
Terumo Corporation partners with HTL-Strefa S.A.: This November 2023 collaboration aims to expand Terumo's reach in the European lancing device market, leveraging HTL-Strefa's expertise and distribution network.
Bayer launches Breeze® 2 lancing device with ComfortGlide™ technology: This July 2023 launch offers a user-friendly option with features like pre-loaded lancets and adjustable depth settings for a more comfortable lancing experience.
Roche introduces Accu-Chek® Guide lancing device with built-in blood ketone testing: This December 2023 innovation allows diabetics to measure both blood glucose and ketones with a single finger prick, providing a more comprehensive picture of their diabetes management.
Ypsomed develops smart lancing devices with integrated sensors: These innovative devices have the potential to improve insulin dosing accuracy and diabetes management through data collection and insights.
List of Diabetic Lancing Device Key companies in the market:
- B. Braun Melsungen AG
- Terumo Corporation
- Becton Dickinson
- Sanofi
- F. Hoffmann-La Roche AG
- Bayer AG
- Novo Nordisk A S
- Eli Lilly and Company
- Owen Mumford Ltd
- Medtronic
